Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries

  title={Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries},
  author={Evan Simpson and Scott Wittet and Josefina Bonilla and Kateryna Gamazina and Laura Cooley and Jennifer L. Winkler},
  journal={BMC Public Health},
  pages={281 - 281}
BackgroundRotavirus gastroenteritis is the leading cause of diarrheal disease mortality among children under five, resulting in 450,000 to 700,000 deaths each year, and another 2 million hospitalizations, mostly in the developing world. Nearly every child in the world is infected with rotavirus at least once before they are five years old.Vaccines to prevent rotavirus or minimize its severity are now becoming available, and have already been introduced into the public vaccine programs of… 

Knowledge of Rotavirus Disease among Health Care Providers and Their Acceptance of Rotavirus Vaccines in South-East, Nigeria

This study suggests that health-care providers are likely to adopt rotavirus vaccines, especially if they are properly informed, and will guide pre-introduction advocacy efforts and help develop strategies to broaden vaccine coverage.

Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.

If the challenges related to the financing of vaccine purchase, the cold chain capacity and vaccine efficacy must be overcome,Rotavirus vaccination could substantially improve child health and survival from rotavirus-associated diarrhoea.

Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

How the development and future availability of newer-generation rotav virus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed is discussed.

Rotavirus vaccination in developing countries.

Therapeutics Insight with Inclusive Immunopharmacology Explication of Human Rotavirus A for the Treatment of Diarrhea

The results suggest that epitope SU1 (TLKNLNDNY) could be an ideal candidate among the predicted five epitopes for both T and B-cell epitope for the development of universal vaccine against rotavirus.

Knowledge and attitudes towards rotavirus diarrhea and the vaccine amongst healthcare providers in Yogyakarta Indonesia

The high cost and the low priority given to this vaccine by the public health authorities are the biggest obstacles impacting on the acceptance of this vaccine in Indonesia.

Rotavirus vaccines: Opportunities and challenges

Rotavirus vaccines remain to be fully evaluated in low-income countries where reduced immunogenicity of oral vaccines, greater strain diversity and difficulties reaching target populations might decrease immunisation programme performance.

Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial

Rotasiil provided protection against SRVGE in infants through an extended follow-up period of approximately 2 years, and protection was significant in the first year of life, when the disease burden and risk of death are highest, and against a changing pattern of rotavirus strains during the 2-year efficacy period.

Nurses Knowledge toward Rotavirus Vaccine for Children at Primary Health Care Centers in Babylon Governorate

Assessment of nurses knowledge towards rotavirus vaccine for children at primary health care centers in Babylon Governorate reveals that the majority of nurses were poor knowledge, and needs to be employed intensive training courses related to immunization program to improve knowledge.

Burden of rotavirus diarrhea in under-five Indian children

Most cases of rotavirus diarrhea in India are caused by G1, G2, and G untypeable strains with distinct regional variations, andRotavirus was identified as an etiological agent in 5.5% cases of nosocomial diarrhea.



Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

This vaccine was efficacious in preventing rotavirus gastroenteritis, decreasing severe disease and health care contacts, and the risk of intussusception was similar in vaccine and placebo recipients.

Rotavirus infection in infants as protection against subsequent infections.

In infants, natural rotavirus infection confers protection against subsequent infection, which increases with each new infection and reduces the severity of the diarrhea.

Rotavirus vaccines--an update.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Two oral doses of the live attenuated G1P[8] HRV vaccine were highly efficacious in protecting infants against severe rotavirus gastroenteritis, significantly reduced the rate of severe gastroenteropathy from any cause, and were not associated with an increased risk of intussusception.

Lessons learned in a pilot introduction of zinc treatment for childhood diarrhea in Bougouni district Mali.

This document reports the lessons learned in a pilot introduction study of zinc treatment for childhood diarrhea in the Bougouni district in southern Mali that took place between April 2003 and

The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000.

Current estimates of the global burden of disease for diarrhoea are reported and compared with previous estimates made using data collected in 1954-79 and 1980-89, finding that the total morbidity component of the disease burden is greater than previously.

Diarrhoea case management in low- and middle-income countries--an unfinished agenda.

The finding that many children in low- and middle-income countries do not receive proper treatment for diarrhoea points to the urgency in addressing this unfinished agenda in child survival.

Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries : Pooled analysis of randomized controlled trials

A pooled analysis of randomized controlled trials in children in developing countries evaluated the effects of zinc supplementation in the prevention of diarrhea and pneumonia with the use of random effects hierarchical models to calculate odds ratios (OR) and 95% CIs.